We are focused on becoming a critical leader in the biopharma industry through a strong portfolio of products that can make a difference. Our mission drives us to treat clinical and social disease burdens while fostering sustainable growth.
XTMAB-16 for Sarcoidosis Learn more about our clinical trialThe current medicine landscape is dominated by “classic” small molecules (drugs created in a lab using traditional drug discovery techniques). While traditional medicines, including small molecule medicines, provide a great benefit to populations, they need to have a well-defined structure to be an effective therapy. As such, the scientific community has turned to what we now refer to as Biologics.
Biologics are larger molecule medicines that are produced by genetically engineering microorganisms to produce specific proteins. The benefit with larger molecule drugs, specifically biologics, is that they can exert their effects on a broader spectrum of targets.
Each phase of research plays an important part in drug development. Find out more about clinical research below.
Learn More!Xentria’s goal is to provide effective therapies to countless patients in need. There are several projects ongoing.
Come Check It Out!We are an evergrowing team in a dynamic industry with opportunity for growth.
Come Join Our Team!